Patent: Phospholipid Composition and Microbubbles and Emulsions Formed Using SameMVTOct 31, 20171 min readREAD PATENT >
Microvascular Therapeutics Showcases Breakthrough Ultrasound Contrast Agent, MVT-100, at the 2025 ICUS Bubble ConferenceChicago, IL – October 7th, 2025 – Microvascular Therapeutics (MVT), a clinical-stage biopharmaceutical company pioneering innovations in...
Microvascular Therapeutics, Inc Named 2025 Most Fundable Company® by Pepperdine Graziadio Business SchoolSalt Lake City (Utah), September 29, 2025: Microvascular Therapeutics (MVT), the leader in development of next-generation ultrasound...
Microvascular Therapeutics Recognized with People’s Choice Award at the American Society of Echocardiography’s Shark Tank CompetitionNashville, TN – September 6, 2025 – Microvascular Therapeutics (MVT), a pioneering Utah-based biotechnology company, is honored to have...
Comments